What we learned from bench to bedside with the neuroblastoma targeting CD171-specific CAR

@inproceedings{Knkele2015WhatWL,
  title={What we learned from bench to bedside with the neuroblastoma targeting CD171-specific CAR},
  author={Annette K{\"u}nkele and A. Johnson and Carolina Berger and Laura S. Finn and Julie Park and M Jensen},
  year={2015}
}
s of the 51st Workshop for Pediatric Research 51st Workshop for Pediatric Research Göttingen, Germany 16-17 April 2015 This supplement has not been sponsored. Meeting abstracts Meeting abstract Despite the therapeutic efficacy of chimeric antigen receptor (CAR) redirected T cell immunotherapy in leukemia and lymphoma patients, similar clinical responses in… CONTINUE READING